Steven Mintz - 21 Jun 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role: Director
Signature: /s/ Steven Mintz
Issuer symbol: SER
Transactions as of: 21 Jun 2024
Net transactions value: +$70,900
Form type: 4
Filing time: 27 Jun 2024, 20:26:37 UTC
Previous filing: 23 May 2024
Next filing: 19 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SER	Common Stock	Purchase	$47,500	+5,000	+151%	$9.50	8,307	21 Jun 2024	Direct
transaction	SER	Common Stock	Purchase	$23,400	+2,600	+31%	$9.00	10,907	25 Jun 2024	Direct
holding	SER	Common Stock						9,900	21 Jun 2024	By Spouse
holding	SER	Common Stock						1,240	21 Jun 2024	By Adult Child 1	F1
holding	SER	Common Stock						1,240	21 Jun 2024	By Adult Child 2	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
F2	The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.

Content

The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.